カテゴリ： MarketLine, 中国, 企業調査

iKang Healthcare Group Inc：企業の戦略・SWOT・財務情報

◆英語タイトル：iKang Healthcare Group Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6906
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：40
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：中国
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

iKang Healthcare Group Inc – Strategy, SWOT and Corporate Finance Report
Summary

iKang Healthcare Group Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

iKang Healthcare Group Inc. (iKang Healthcare) is a provider of preventive healthcare solutions. The group offers medical examinations services such as gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound and X-ray. Its value-added services include disease screening, dental services and outpatient services. iKang Healthcare also has on-site healthcare management or clinics. It primarily operates in China. iKang Healthcare is headquartered in Beijing, China.

Scope

- Detailed information on iKang Healthcare Group Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting iKang Healthcare Group Inc in the form of a SWOT analysis
- An in-depth view of the business model of iKang Healthcare Group Inc including a breakdown and examination of key business segments
- Intelligence on iKang Healthcare Group Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about iKang Healthcare Group Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of iKang Healthcare Group Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess iKang Healthcare Group Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on iKang Healthcare Group Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
iKang Healthcare Group Inc: Company Overview 9
iKang Healthcare Group Inc: Overview and Key Facts 9
iKang Healthcare Group Inc: Overview 9
iKang Healthcare Group Inc: Key Facts 9
iKang Healthcare Group Inc: Key Employees 10
iKang Healthcare Group Inc: Key Employee Biographies 11
iKang Healthcare Group Inc: Major Products and Services 15
iKang Healthcare Group Inc: Company History 16
iKang Healthcare Group Inc: Management Statement 19
iKang Healthcare Group Inc: Locations and Subsidiaries 20
iKang Healthcare Group Inc: Key Competitors 21
iKang Healthcare Group Inc: Company Analysis 22
iKang Healthcare Group Inc: Business Description 22
iKang Healthcare Group Inc: SWOT Analysis 23
iKang Healthcare Group Inc: SWOT Overview 23
iKang Healthcare Group Inc: Strengths 23
iKang Healthcare Group Inc: Weaknesses 24
iKang Healthcare Group Inc: Opportunities 24
iKang Healthcare Group Inc: Threats 25
iKang Healthcare Group Inc: Corporate Financial Deals Activity 27
iKang Healthcare Group Inc: Financial Deals Overview 27
iKang Healthcare Group Inc: Targets and Partners 28
iKang Healthcare Group Inc: Top Deals 2014 – 2018YTD* 29
iKang Healthcare Group Inc: Advisors 30
iKang Healthcare Group Inc: Top Legal Advisors 30
iKang Healthcare Group Inc: Top Financial Advisors 30
iKang Healthcare Group Inc: Mergers and Acquisitions 31
iKang Healthcare Group Inc: Capital Raising 32
iKang Healthcare Group Inc: Private Equity and Ownership 33
iKang Healthcare Group Inc: Recent Developments 34
iKang Healthcare Group Inc: News and Events Summary 34
iKang Healthcare Group Inc: Business Expansion 35
iKang Healthcare Group Inc: Financial Deals 35
iKang Healthcare Group Inc: Financial Performance 36
Appendix 38
Contact Us 38
Methodology 38
About MarketLine 39

List of Tables
Table 1: iKang Healthcare Group Inc: Key Facts
Table 2: iKang Healthcare Group Inc: Key Employees
Table 3: iKang Healthcare Group Inc: Company History
Table 4: iKang Healthcare Group Inc: Locations and Subsidiaries
Table 5: iKang Healthcare Group Inc: Key Competitors
Table 6: iKang Healthcare Group Inc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: iKang Healthcare Group Inc: Targets and Partners
Table 8: iKang Healthcare Group Inc: Top Deals 2014 - 2018YTD*
Table 9: iKang Healthcare Group Inc: Legal Advisor Ranking by Value (US$m)
Table 10: iKang Healthcare Group Inc: Financial Advisor Ranking by Value (US$m)
Table 11: iKang Healthcare Group Inc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: iKang Healthcare Group Inc: M&A Activity by Geography (2014 - YTD*2018)
Table 13: iKang Healthcare Group Inc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: iKang Healthcare Group Inc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: iKang Healthcare Group Inc: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 16: iKang Healthcare Group Inc: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 17: iKang Healthcare Group Inc: News and Events Summary
Table 18: iKang Healthcare Group Inc: Business Expansion
Table 19: iKang Healthcare Group Inc: Financial Deals
Table 20: iKang Healthcare Group Inc: Financial Performance

List of Figures
Figure 1: iKang Healthcare Group Inc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: iKang Healthcare Group Inc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: iKang Healthcare Group Inc: M&A Activity by Geography (2014 - YTD*2018)
Figure 4: iKang Healthcare Group Inc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 5: iKang Healthcare Group Inc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 6: iKang Healthcare Group Inc: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 7: iKang Healthcare Group Inc: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[iKang Healthcare Group Inc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Zhongtian Technology Co., Ltd. (600522)：企業の財務・戦略的SWOT分析
    Zhongtian Technology Co., Ltd. (600522) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Lagerwey Wind BV-エネルギー分野：企業M&A・提携分析
    Summary Lagerwey Wind BV (Lagerwey) is an alternative energy company that design and manufacture of wind turbines. The company’s wind turbines include L82-2.0 MW, L93 1.5 MW, L93 2.6 MW, L100 1.5 MW, L100 2.5 MW, L100- NL and L132-3.8 MW. Its technologies comprise turbine modular set-up, Nacelle, ge …
  • Merus NV (MRUS)：企業の財務・戦略的SWOT分析
    Summary Merus NV (Merus) discovers and develops antibody therapeutics for cancer indications. The company is investigating MCLA-128, for the treatment of metastatic breast cancer and solid tumors; MCLA-117 designed to harness and activate T-cells to kill CLEC12A-expressing acute myeloid leukemia (AM …
  • Takara Holdings Inc.：企業の戦略・SWOT・財務分析
    Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Dyadic International Inc (DYAI)：企業の財務・戦略的SWOT分析
    Summary Dyadic International Inc (Dyadic) is a biotechnology company that develops gene expression platform for production of industrial enzymes and other proteins. The company utilizes C1 technology, an expression system based on the fungus Myceliophthora thermophila, to discover and manufacture bi …
  • Discovery Communications, Inc.
    Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Nonin Medical Inc：医療機器：M&Aディール及び事業提携情報
    Summary Nonin Medical Inc (Nonin) is a medical device company that provides medical monitoring solutions. The company provides noninvasive physiological monitoring devices for health professionals and consumers. Its products include pulse oximeters and sensors, regional oximeters and sensors, finger …
  • International Dairy Queen, Inc.：企業の戦略・SWOT・財務情報
    International Dairy Queen, Inc. - Strategy, SWOT and Corporate Finance Report Summary International Dairy Queen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Rentokil Initial plc (RTO)：企業の財務・戦略的SWOT分析
    Rentokil Initial plc (RTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • ALK-Abello AS (ALK B)：企業の財務・戦略的SWOT分析
    ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Trafigura Beheer BV：石油・ガス：M&Aディール及び事業提携情報
    Summary Trafigura Beheer BV (Trafigura Beheer) is an independent commodity trading and logistics company. The company’s investments portfolio includes crude and petroleum products, non-ferrous concentrates, refined metals and bulk commodities, and shipping and chartering. Its oil and petroleum produ …
  • Citius Pharmaceuticals Inc (CTXR)：企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • Terumo Corp (4543)：企業の財務・戦略的SWOT分析
    Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • J&P – Avax Sa
    J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report Summary J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Brioche Pasquier S.A.：企業の戦略・SWOT・財務分析
    Brioche Pasquier S.A. - Strategy, SWOT and Corporate Finance Report Summary Brioche Pasquier S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Energy Development Corp (EDC)：電力：M&Aディール及び事業提携情報
    Summary Energy Development Corp (EDC), formerly Philippine National Oil Company, is a diversified renewable energy company. The company explores, develops, operates and utilizes geothermal energy and other indigenous renewable energy projects in the Philippines. EDC by utilizing geothermal energy an …
  • Tauron Polska Energia SA：発電所・企業SWOT分析
    Tauron Polska Energia SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • DiaMedica Therapeutics Inc (DMA)：企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica), formerly DiaMedica Inc is a clinical-stage biopharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 a …
  • Saint-Gobain Ltd：企業の戦略的SWOT分析
    Saint-Gobain Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Redbiotec AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing prod …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆